In his letter to the editor published in the Journal of Clinical Oncology, IVI’s Evidence Synthesis Expert, Jeroen Jansen, argues that network meta-analysis is the only transparent framework to help answer the treatment selection question.
Responding to his letter, members of the ASCO Task Force reply that Dr. Jansen makes a “strong argument for the use of network meta-analysis” and that “the ASCO Value in Cancer Care Task Force is well aware of the legitimacy of this concern and we appreciate the recommendation to incorporate this methodological approach in future refinements of the value framework.”
Read the full letter here.
